Novavax, Inc. (NVAX)
9.68
-0.43
(-4.25%)
USD |
NASDAQ |
Mar 03, 13:41
Novavax Total Liabilities (Quarterly) : 1.311B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 84.20B |
| Pfizer Inc. | 121.38B |
| Moderna, Inc. | 3.688B |
| Intellia Therapeutics, Inc. | 170.73M |
| Recursion Pharmaceuticals, Inc. | 397.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.183B |
| Shareholders Equity (Quarterly) | -127.75M |
| Debt to Equity Ratio | -2.176 |
| Current Ratio | 2.127 |
| Net Debt Paydown Yield | -0.82% |